Pharmaceuticals from Microbes
Impact on Drug Discovery
(Sprache: Englisch)
This book deals with the noteworthy advancement in the production of bioactive metabolites from microbes and their pharmacological significance. It highlights the pharmacological potential of marine microbes and endophytic fungi and their...
Jetzt vorbestellen
versandkostenfrei
Buch (Gebunden)
Fr. 201.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Pharmaceuticals from Microbes “
Klappentext zu „Pharmaceuticals from Microbes “
This book deals with the noteworthy advancement in the production of bioactive metabolites from microbes and their pharmacological significance. It highlights the pharmacological potential of marine microbes and endophytic fungi and their bioactive secondary metabolites. Emphasis is also given on the significance of probiotics and their specialized molecules in human health and disease as well as their role in dietary intervention for reducing the risk of non-alcoholic fatty liver disease. This work also serves as excellent reference material for researchers, students and academicians in the field of natural product chemistry, pharmacology and applied microbiology.
Inhaltsverzeichnis zu „Pharmaceuticals from Microbes “
1. Pharmacological potential of marine microbes.- 2.Antiparasitics from microorganisms: current status and future prospects.- 3. Bioactive compounds from Nocardia: biosynthesis and production.- 4. Bioactive metabolites from microorganisms for healthcare: types and delivery routes.- 5. Siderophores: A novel approach to fight antimicrobial resistance.- 6. An update on bioactive natural products from endophytic fungi of medicinal plants.- 7. Microbes, their metabolites and effector molecules: a pharmacological perspective for host-microbiota interaction.- 8. Probiotics as a dietary intervention for reducing the risk of non-alcoholic fatty liver disease.
Autoren-Porträt
Divya Arora is working in Microbial Biotechnology Division at CSIR- Indian Institute of Integrative Medicine, Jammu. She has obtained her Ph.D. from the Academy of Scientific and Innovative Research (AcSIR) at the CSIR-Indian Institute of Integrative Medicine, Jammu. Chetan Sharma is working as Research Associate, College of Dairy Science and Technology, Guru Angad Dev Veterinary and Animal Science University, Ludhiana, India.
Sundeep Jaglan, 38, is working as Scientist in the Microbial Biotechnology Division atthe CSIR-Indian Institute of Integrative Medicine, Jammu, India.
Eric Lichtfouse, 58, is a biogeochemist at the University of Aix-Marseille, France. He is the inventor of carbon-13 dating and author of the book Scientific Writing for Impact Factor Journals. He is Chief Editor and founder of Environmental Chemistry Letters, Sustainable Agriculture Reviews and Environmental Chemistry for a Sustainable World (Springer Nature), and Publier La Science (INRA). His actual research interests include soil carbon sequestration and temporal pools of individual substances in complex media.
Bibliographische Angaben
- 2019, 1st ed. 2019, XIII, 226 Seiten, 16 farbige Abbildungen, Masse: 16,1 x 24,3 cm, Gebunden, Englisch
- Herausgegeben: Divya Arora, Chetan Sharma, Sundeep Jaglan, Eric Lichtfouse
- Verlag: Springer, Berlin
- ISBN-10: 3030046745
- ISBN-13: 9783030046743
Sprache:
Englisch
Kommentar zu "Pharmaceuticals from Microbes"
0 Gebrauchte Artikel zu „Pharmaceuticals from Microbes“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Pharmaceuticals from Microbes".
Kommentar verfassen